引用次数
引用: 914
H-指数: 18
I10-指数 : 22
出版物: 60
Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
Kittrick Brian Mc , Kristin E Rosner , Zhuyan Guo , Lianyun Zhao
56
2005
Modulation of the Gut Microbiome by Novel Synthetic Glycans for the Production of Propionate and the Reduction of Cardiometabolic Risk Factors
Yves A Millet , Jeffrey Meisner , Jie Tan , Adarsh Jose
bioRxiv 2022.04. 04.487010 -2022.04. 04.487010
2022
KB39, A NOVEL SYNTHETIC GLYCAN MODULATING THE GUT MICROBIOME, DECREASES FATTY LIVER AND ATHEROSCLEROSIS IN DIET-INDUCED MURINE MODELS OF NON-ALCOHOLIC FATTY LIVER AND CARDIOVASCULAR DISEASE
Yves Millet , Jie Tan , Jeffrey Meisner , Adarsh Jose
HEPATOLOGY 72 372A -372A
2020
Imidazopyrazines as cyclin dependent kinase inhibitors
Timothy J Guzi , Kamil Paruch , Michael P Dwyer , Lianyun Zhao
26
2009
Substituted pyrazolo [1, 5-a] pyrimidines as protein kinase inhibitors
Timothy J Guzi , Kamil Paruch , Michael P Dwyer , M Arshad Siddiqui
24
2009
Substituted pyridines that are JNK inhibitors
David B Belanger , M Arshad Siddiqui , Patrick J Curran , Blake Hamann
21
2012
Novel jnk inhibitors
Panduranga Adulla P Reddy , M Arshad Siddiqui , Praveen K Tadikonda , Umar Faruk Mansoor
21
2010
Compounds for the treatment of inflammatory disorders
Zhuyan Guo , Peter Orth , Zhaoning Zhu , Robert D Mazzola
18
2010
Imidazopyrazines as protein kinase inhibitors
David B Belanger , M Arshad Siddiqui , Timothy J Guzi , Patrick J Curran
8
2009
Pyrazolo [1, 5-a] pyrimidine compounds as mTOR inhibitors
M Arshad Siddiqui , Yang Nan , Mehul F Patel , Panduranga Adulla P Reddy
7
2016
Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis
M Arshad Siddiqui , David B Belanger , Chaoyang Dai , Lianyun Zhao
5
2008
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
David B Belanger
5
2002
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye
David B Belanger
4
2002
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
David B Belanger
4
2001
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
David B Belanger
3
2001
3
2001
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Christopher M Adams , David B Belanger , Doug Bevan , Philippe Bolduc
1
2018
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
Christopher M Adams , David B Belanger , Doug Bevan , Takeru Ehara
1
2017
Discovery of potent imidazo [1, 2-a] pyrazine Aurora kinase inhibitors
David B Belanger , Patrick J Curran , Alan Hruza , Johannes Voigt
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240
1
2010
From isothiazole to thiophene and thiazole: A bioisosteric approach to the discovery of potent imidazo [1, 2-a] pyrazines as Aurora kinase inhibitors
Zhaoyang Meng , Bheemashankar A Kulkarni , Angela D Kerekes , Johannes Voigt
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240
2010